Patent ID: 11912663
Assignee: SHANGHAI AB PHARMATECH LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The compound according to claim 3, wherein
E is CH;
G1 is H;
G2 is —OR6, wherein R6 is independently selected from H, deuterium (D), C1-6 alkyl, C1-6 haloalkyl, C1-6 cyanoalkylidene, C4-6 cyanocycloalkylidene, C2-6 hydroxyalkylidene, C3-6 hydroxycycloalkylidene, C2-6 aminoalkylidene, C3-6 aminocycloalkylidene, C2-6 carboxyalkylidene, C4-6 carboxycycloalkylidene, C3-6 cycloalkyl, C3-6 aminocycloalkylidene, C1-6 amino(C3-6cycloalkyl)alkylidene, 3-6 members heterocycloalkyl, or 3-6 members heterocycloalkylidene group;
G3 is independently selected from C(O)OR, C(O)NH2, or a C(O)NR4R5 group, wherein, R is H, or C1-6 alkyl, R4 and R5 are each independently selected from H, C1-6 alkyl, C1-6 haloalkyl, C1-6 cyanoalkylidene, C4-6 cyanoalkylidene, C2-6 hydroxyalkylidene, C2-6 aminoalkylidene, C3-6 cycloalkyl, 3-6 members heterocyclic, 3-6 members heterocyclic alkylidene, C3-6 heterocyclic aryl, C1-6 alkyl sulfonyl, C3-6 cycloalkyl sulfonyl, or C2-6 heterocycloalkyl sulfonyl group; or R4 and R5 are interconnected into a heterocyclic group or a heterocyclic aryl, of 3-8 members containing 1-3 heteroatoms;
G4 and G5 are each independently selected from H;
R1 is H;
R2 and R3 are each independently selected from H, or C3-6 cycloalkyl group;
X1, X2 and X3 are each independently selected from halogen;
X4 is H.